Olema Oncology

Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our pipeline also

• Team: 51-200
• Founded: 2007
• Headquarters: San Francisco, CA, United States
• Funding: Public
• Sectors: Biotech
• Investors: Adage Capital Partners, Bain Capital Life Sciences, BVF Partners, Janus Henderson Investors, Wellington Management

13 open roles

• Principal Talent Acquisition Partner — San Francisco, California — $190k - $225k
• Medical Director, Clinical Development — Boston, Massachusetts — $275k - $300k
• Senior Manager, Clinical Supply Integration — San Francisco, California — $150k - $160k
• Senior Director, Patient Safety Sciences — San Francisco, California
• Vice President of Information Technology — San Francisco, California — $335k - $365k
• Director, Commercial Insights and Analytics — San Francisco, California — $230k - $250k
• Associate Director, Global Regulatory Affairs, Compliance and Project Management — San Francisco, California — $185k - $205k
• Director, Compensation — San Francisco, California — $230k - $250k
• Executive Assistant, supporting Chief Financial Officer — San Francisco, California — $120k - $150k
• Senior Director, National and Strategic Accounts — Remote — $250k - $275k
• Senior Director, EU Regulatory Strategy — Dublin, Ireland
• Medical Science Liaison/Senior Medical Science Liaison (Southeast Region) — Remote
• Associate Director, Clinical Supply Chain — Boston, Massachusetts — $185k - $200k